Current Issue

May 02, 2016
Pharmaceutical Technology
In a move to encourage drug development, EU regulators are offering scientific advice to companies on major efficacy, safety, and quality issues at an early stage.
May 02, 2016
Pharmaceutical Technology
This article examines using experimental design methods to define different procedures for intermediate bulk container cleaning. The authors have evaluated this new approach, in which a highly soluble, low-dose product and a relatively insoluble high-dose product constituted experimental input variables.
May 02, 2016
Pharmaceutical Technology
With deadlines only a few years away, some companies have not started serialization programs, while others are taking a tactical, short-term approach, losing out on potential business benefits.
May 02, 2016
Pharmaceutical Technology
Application for sirdupla uniformity of delivered dose methodology.
May 02, 2016
Pharmaceutical Technology
Troubleshooting and collaboration are essential in implementing commercial lyophilization processes.
May 02, 2016
Pharmaceutical Technology
Policies for patient access to life-saving therapies must keep pace with biomedical innovation.
May 02, 2016
Pharmaceutical Technology
Bioprocess operations—from cell line selection to final filtration—can influence the consistency and purity of biologic drug substances.
May 02, 2016
Pharmaceutical Technology
Revisions and updates for the 9th Edition of the European Pharmacopoeia result in changes to more than half of the content.
May 02, 2016
Pharmaceutical Technology
Siegfried Schmitt, Principal Consultant, PAREXEL International, discusses how to report quality metrics to FDA.
May 02, 2016
Pharmaceutical Technology
As the pharmaceutical industry moves toward continuous manufacturing, new documents are needed to provide flexible guidance that meets the new process requirements.
lorem ipsum